“Tralokinumab versus Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis with Hand Involvement: a Matching-Adjusted Indirect Comparison” (2026) SKIN The Journal of Cutaneous Medicine, 10(2), p. s725. doi:10.25251/24g02225.